drugset / Trial / NCT00102674

Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor

NCT00102674

Phase 1 Completed 40 enrolled The Medicines Company
RandomizedSingle-groupOpen-labelTreatment

Summary

The purposes of this study are to: * Evaluate the tolerability of two cangrelor regimens. * Compare the PD of cangrelor regimens with oral clopidogrel.

Timeline

Start
2005-03
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Cangrelor Small molecule

Indications

No indication recorded.